Phragma Therapeutics (Thera Phragma)
About
Phragma Therapeutics Inc. and its Greek Subsidiary Thera Phragma IKE is a biotechnology company specializing in the research and development of innovative therapies to address diseases related to the function of biological protective barriers of vital organs, such as the brain, the eye, and the intestine. The company's leading program aims to restore the pathological function of the Blood-Brain Barrier (BBB) to treat Central Nervous System (CNS) conditions of high unmet medical need. The company is also developing a proprietary platform technology to enhance the permeability of therapeutic agents (such as gene, cell, and RNA therapies, as well as other macromolecules) into the CNS, improving their efficacy and targeted action in patients with brain disorders.
Research & Innovation
Health & Life Sciences
Representatives
Vice President, Head of Biology
Phragma Therapeutics (Thera Phragma)